READ ME FIRST - Patent Application Updates 6/19/08 1. TRANSGENICALLY PRODUCED ANTITHROMBIN III AND MUTANTS THEREOF <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=ES2299425T&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=ES2299425T&F=0</a> 2. Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US2008118501&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US2008118501&F=0</a> 3. Novel modified MSP-1 nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=AU2003200911B&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=AU2003200911B&F=0</a> 4. Methods of protein fractionation using high performance tangential flow filtration <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=CN101027080&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=CN101027080&F=0</a>' 5. A METHOD OF USING AN ANTI-CD137 ANTIBODY AS AN AGENT FOR RADIOIMMUNOTHERAPY OR RADIOIMMUNODETECTION <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1850872&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1850872&F=0</a> 6. AN ANTI-CD137 ANTIBODY AS AN AGENT IN THE TREATEMENT OF CANCER AND GLYCOSYLATION VARIANTS THEREOF <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1851244&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1851244&F=0</a> 7. METHODS AND PRODUCTS RELATED TO THE TRANSFER OF MOLECULES FROM BLOOD TO THE MAMMARY GLAND <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007124019&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007124019&F=0</a> 8. CLARIFICATION OF TRANSGENIC MILK USING DEPTH FILTRATION <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007106078&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2007106078&F=0</a> 9. Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US7271312&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US7271312&F=0</a> 10. ERYTHROPOIETIN ANALOG-HUMAN SERUM ALBUMIN FUSION <a href="http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=DE69933216T&F=0" target="_blank">http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=DE69933216T&F=0</a> Intellectual property - Compliments of DEW <a href='read_msg.asp?message_id=22560060'>#msg-22560060</a> “Milk” patent <a href='read_msg.asp?message_id=7179529'>#msg-7179529</a> Purification patent <a href='read_msg.asp?message_id=18949245'>#msg-18949245</a> IP summary from most recent 10K report <a href='read_msg.asp?message_id=25410579'>#msg-25410579</a> Musings on fibrinogen IP <a href='read_msg.asp?message_id=18615705'>#msg-18615705</a> Nuclear-transfer license from Geron <a href='read_msg.asp?message_id=19226707'>#msg-19226707</a> Notes on nuclear-transfer license